Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxoprexin in metastatic colorectal cancer
NCT00024401Phase 2Unknown
- Sponsor
- Theradex Oncology
- Start
- May 2001
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel docosahexaenoic acid in colorectal cancer (CRC), sponsored by Theradex Oncology. Primary endpoints: Objective Tumor Response Rate, Duration of Response and 1 more. Status: unknown.
02
Drugs
paclitaxel docosahexaenoic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00024401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024401.